Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Nov 12, 2021 1:08pm
222 Views
Post# 34120427

RE:RE:RE:Therma Bright to Begin AcuVid(TM) U.S. Clinical Performance

RE:RE:RE:Therma Bright to Begin AcuVid(TM) U.S. Clinical Performance

I'm hoping you're being sarcastic, midas!!! Did you actually read the NR?

It's the FDA that requested this additional testing (which is a positive development) thus it has everything to do with the FDA decision. As it says in the NR and that one can speculate from it and previous ones, the FDA has considered and reviewed all the other data ....positively. This cross reactivity testing is to make sure that other infections don't influence the reliability of AcuVid. This should be the final step to the EUA.

As it states in the NR, yes, more time in the order of a few weeks to complete the testing and present the results for a final analysis by the FDA. 

This could very well be the Christmas present we've all been waiting for.

GLTY ....and GLTE ...looking forward to the results.


1518midas wrote: Does this have any bearing on the FDA decision, if so, that means we have longer to wait. increased volume suggests news soon though......

 

<< Previous
Bullboard Posts
Next >>